Krystal Biotech Stock Surges 21.9% in 3 Months: More Room to Grow? [Yahoo! Finance]
Krystal Biotech, Inc. (KRYS)
Last krystal biotech, inc. earnings: 11/4 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.krystalbio.com/investors
Company Research
Source: Yahoo! Finance
Shares of Krystal Biotech, Inc . KRYS, a commercial-stage biotechnology company, have surged 21.9% year to date compared with the industry's growth of 7.8%. The stock has also outperformed the Medical sector and S&P 500 Index during the same timeframe. The rally can be mostly attributed to the strong uptake of its newly approved drug Vyjuvek and encouraging pipeline progress. Earlier this month, the company reported better-than-expected second-quarter results, wherein both earnings and sales beat their respective estimates. KRYS Outperforms Industry, Sector & S&P 500 Image Source: Zacks Investment Research KRYS' Vyjuvek: Strong Update In May 2023, the FDA approved Vyjuvek, the first-ever revocable gene therapy for treating patients aged six months or older with dystrophic epidermolysis bullosa (DEB). DEB is a rare and severe monogenic disease that affects the skin and mucosal tissues. It is caused by one or more mutations in a gene called COL7A1. The drug, launched in
Show less
Read more
Impact Snapshot
Event Time:
KRYS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KRYS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KRYS alerts
High impacting Krystal Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
KRYS
News
- Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025GlobeNewswire
- Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Jeune Aesthetics Appoints Nishant Saxena as Chief Financial OfficerGlobeNewswire
- City Therapeutics Appoints Andy Orth as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Krystal Biotech, Inc. (NASDAQ:KRYS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? [Yahoo! Finance]Yahoo! Finance
KRYS
Earnings
- 11/4/24 - Beat
KRYS
Sec Filings
- 2/5/25 - Form SCHEDULE
- 12/18/24 - Form 8-K
- 12/13/24 - Form 4
- KRYS's page on the SEC website